SCHEMBL22685994

SCHEMBL22685994

O=C1OCCN1c1ccc2[nH]nc(-c3cccc(Cl)c3)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.45
PIM1 P11309 4/20 0.43
IDH1 O75874 3/20 0.41
TNKS O95271 1/20 0.40
MEN1 O00255 5/20 0.38
ALDH1A1 P00352 5/20 0.38
MAPT P10636 5/20 0.38
KMT2A Q03164 5/20 0.38
L3MBTL1 Q9Y468 5/20 0.38
HPGD P15428 4/20 0.38
GLA P06280 3/20 0.38
GAA P10253 1/20 0.38
NOTUM Q6P988 1/20 0.38
TDP1 Q9NUW8 3/20 0.38
ATM Q13315 2/20 0.38
MAP2K4 P45985 1/20 0.38
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
RECQL P46063 1/20 0.37
MAPK11 Q15759 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22686000 0.88 TTK (0.46) JAK2PIM1TNKSMAPTHPGD
SCHEMBL22686003 0.88 IDH1 (0.43) PIM1IDH1TNKSMAP2K4CCNC
SCHEMBL22685937 0.88 TNKS (0.48) PIM1TNKSALDH1A1MAPTHPGD
SCHEMBL22685979 0.85 TNKS (0.49) JAK2PIM1TNKSALDH1A1MAPT
SCHEMBL22685957 0.83 MAP2K4 (0.54) PIM1MAP2K4CCNCCDK8
SCHEMBL22685984 0.83 MKNK1 (0.45) JAK2PIM1TNKSCCNCCDK8
SCHEMBL22685983 0.83 TNKS (0.47) PIM1IDH1TNKSNOTUMMAP2K4
SCHEMBL22708149 0.81 IDH1 (0.51) IDH1
SCHEMBL22685966 0.81 ITK (0.42) PIM1IDH1TNKSCCNCCDK8
SCHEMBL22686016 0.80 CCNC (0.43) PIM1IDH1TNKSMAP2K4CCNC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11396505-B2 Inhibitors of CaMKK2 and uses of same NEW YORK UNIVERSITY (US) 2022-07-26 US disclosed
US-11396505-B2 Inhibitors of CaMKK2 and uses of same NEW YORK UNIVERSITY (US) 2022-07-26 US disclosed
US-20200369656-A1 INHIBITORS OF CAMKK2 AND USES OF SAME NEW YORK UNIVERSITY 2020-11-26 US disclosed
US-20200369656-A1 INHIBITORS OF CAMKK2 AND USES OF SAME NEW YORK UNIVERSITY 2020-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11396505-B2 Inhibitors of CaMKK2 and uses of same CAMKK2, CAMKK1, CAMK1 JAK2 1767/4885PIM1 817/4885IDH1 1375/4885
US-20200369656-A1 INHIBITORS OF CAMKK2 AND USES OF SAME CAMKK2, CAMKK1, CAMK1 JAK2 1767/4885PIM1 817/4885IDH1 1375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.